Gastrointestinal bleeding and pro-angiogenic shift in the angiopoietin axis with continuous flow left ventricular

Adam L Edwards1, C Mel Wilcox1, Mark Beasley2

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Insights

Continuous-flow left ventricular assist device (CF-LVAD) recipients with gastrointestinal bleeding (GIB) show altered angiopoietin levels. Lower angiopoietin-1 and higher angiopoietin-2 are linked to GIB and may be associated with low pulse pressure.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Gastroenterology

Background:

  • Gastrointestinal bleeding (GIB) affects up to 40% of continuous-flow left ventricular assist device (CF-LVAD) recipients.
  • Low device pulsatility is a risk factor for GIB in CF-LVAD patients, but the underlying mechanism is unknown.
  • Altered hemodynamics in CF-LVAD recipients may impact angiogenesis signaling.

Purpose of the Study:

  • To measure serum levels of angiopoietin (Ang)-1, Ang-2, and VEGF-A in CF-LVAD recipients with and without GIB, and in healthy controls.
  • To evaluate correlations between these angiopoietin levels and hemodynamic parameters in CF-LVAD recipients.

Main Methods:

  • Recruited 12 CF-LVAD recipients (6 with GIB) and 12 age-matched controls.
  • Measured serum Ang-1, Ang-2, and VEGF-A levels.
  • Correlated angiopoietin levels with device hemodynamics, including pulse pressure.

Main Results:

  • CF-LVAD recipients had higher Ang-2 and lower Ang-1 levels than controls; VEGF-A levels were similar.
  • CF-LVAD recipients with GIB had lower Ang-1 levels compared to those without GIB.
  • Trends suggested pulse pressure positively correlated with Ang-1 and negatively with Ang-2 in CF-LVAD recipients.

Conclusions:

  • CF-LVAD recipients exhibit a pro-angiogenic shift in the angiopoietin axis.
  • This shift is significantly associated with GIB and potentially linked to low pulse pressure.
  • Understanding these vascular changes may inform strategies to reduce GIB in CF-LVAD patients.
Abstract